NeoDynamics to attend session with HC Andersen Capital. Will discuss planned US launch.

NeoDynamics today announced it would participate in a Q&A session with HC Andersen Capital on September 21 to discuss the company’s planned US launch of its innovative pulse biopsy system NeoNavia® after receiving approval from the US Food and Drug Administration, FDA, in September 2022.

The company is moving quickly to push its US strategy

“The FDA approval for NeoNavia earlier this month is a critical step for NeoDynamics as the US represents potentially the largest market for the product valued at $830 million by 2025,” said Anna Eriksrud, CEO of NeoDynamics.

Registration i open

“The company is moving quickly to push its US strategy, which is similar to the plan that is now being executed on in Europe.”

NeoDynamics’s CEO Anna Eriksrud, and CFO Aaron Wong will present at the Q&A.

Participants can register here to join the event on September 21 at 11:00 to 11.30 CEST.

Story tags:

I see great potential in gaining access to a larger network, to exchange experiences and technical knowledge

22

Carolina Jaworski

Merus Power wins 13-million-euro order

19

Jonna Kannosto

Secure Payment Solution Compliant with New EU Directive

DEFA, a leader in EV charging technology, has extensive experience in delivering OCPP 2,0,1 as a standard for its 22 kW AC charger, DEFA Power. This next-generation solution ensures seamless integration with existing and future charging infrastructure while elevating the user experience for EV owners.

138

Unni Amundsen

Funding forecast for 2025: SEK 150-170 billion

27

Victoria Preger

News table

Passive Income – The Holy Grail

HDL Group Strengthens team with new Senior Lead Cloud Engineer

New export success for Swedish Bee Company - The Honey of Sweden on its way to Japan

Nanophotonics "shrinks the light"

Common in optical components. The light wavelength is of the order of 1 micrometre.

17

Lars Thylen